Showing results (501-510 of 4,634) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|August 1, 1991
Recombinant human granulocyte macrophage colony-stimulating factor: current status of clinical trials and potential future applicationsD J Dunlop, W P Steward
Anti-Cancer Drugs|August 1, 1991
Phase I evaluation of 773U82.HCl, a member of a new class of DNA intercalatorsK A Havlin, J G Kuhn, J B Craig, et al.
Anti-Cancer Drugs|August 1, 1991
Risk factors in intermediate and high-grade non-Hodgkin's lymphomas of adults: a need for a new staging systemK A el-Ghamrawy, H Z Zawam, H Abdel-Azim, et al.
Anti-Cancer Drugs|August 12, 2008
Variable association between Chlamydophila psittaci infection and ocular adnexal lymphomas: methodological biases or true geographical variations?Didier Decaudin, Riccardo Dolcetti, Patricia de Cremoux, et al.
Anti-Cancer Drugs|August 12, 2008
Complete pathological response of hepatocellular carcinoma with systemic combination chemotherapyDaris Ferrari, Giuseppe Di Maria, Nicola Fazio, et al.
Anti-Cancer Drugs|October 2, 2008
Agents from amphibians with anticancer propertiesChuang-Xin Lu, Ke-Jun Nan, Yan Lei
Anti-Cancer Drugs|October 2, 2008
Galloyl cyclic-imide derivative CH1104I inhibits tumor invasion through suppressing matrix metalloproteinase activityMing-Hui Chen, Shu-Xiang Cui, Yan-Na Cheng, et al.
Anti-Cancer Drugs|October 2, 2008
Activity of lipoplatin in tumor and in normal cells in vitroChiara Arienti, Anna Tesei, Alberto Ravaioli, et al.
Anti-Cancer Drugs|October 2, 2008
Squalenoyl nanomedicine of gemcitabine is more potent after oral administration in leukemia-bearing rats: study of mechanismsLakkireddy Harivardhan Reddy, Humberto Ferreira, Catherine Dubernet, et al.
Anti-Cancer Drugs|October 2, 2008
Reducing anti-DT IgG concentrations to improve the efficacy of a diphtheria fusion proteinPhilip D Hall, Kathryn L Beagle, Elizabeth Garrett-Mayer, et al.
Pageof 464